Skip to main content

Table 2 Univariate and Multivariable Linear Regression Analyses for Log-transformed Plasma Adiponectin (μg/mL) in Overall Participants (n = 189)

From: Correlation between plasma ZAG and adiponectin in older adults: gender modification and frailty specificity

Variable

Univariate

Multivariable

Estimate

SE

P-value

Estimate

SE

P-value

Age (year)

0.00603

0.00323

0.0634

   

Sex (female)

0.05127

0.03951

0.1961

   

Smoke status

− 0.02789

0.03353

0.4067

   

 Never

Reference

     

 Quitted

− 0.04284

0.04372

0.3286

   

 Smoking

−0.02436

0.08928

0.7853

   

Body composition

 BMI (kg/m2)

−0.01790

0.00569

0.0020

0.00029

0.00998

0.9765

 Waist circumference (cm)

−0.00542

0.00196

0.0062

−0.00432

0.00315

0.1728

 ASMI (kg/m2)

−0.03647

0.01764

0.0403

−0.02178

0.02053

0.2904

 Fat mass percentage (%)

−0.00386

0.00244

0.1160

   

Co-morbidity

 Hypertension

− 0.11024

0.05183

0.0349

− 0.11649

0.04938

0.0196

 Hyperlipidemia

−0.08334

0.04024

0.0399

−0.05997

0.03844

0.1208

 Diabetes mellitus

−0.02586

0.04000

0.5188

   

 Coronary artery disease

−0.07794

0.04229

0.0671

   

 Stroke

0.05794

0.04460

0.1957

   

Medication

 β-blockers

−0.04845

0.04606

0.2944

   

 Calcium channel blockers

−0.05271

0.03954

0.1843

   

 ACEIs or ARBs

−0.02609

0.03994

0.5144

   

 Metformin

−0.05150

0.04497

0.2538

   

 Thiazolidinediones

0.22701

0.07218

0.0020

0.20538

0.07107

0.0044

Frail (robust, pre-frail, frail)

0.08571

0.02883

0.0034

0.04265

0.02931

0.1476

Log (ZAG (μg/ml))

0.52924

0.17022

0.0022

0.45313

0.16997

0.0085

  1. BMI body mass index; ASMI appendicular skeletal muscle index; ACEIs angiotensin-converting enzyme inhibitors; ARBs angiotensin II receptor blockers